Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune

Gesa Ladewig1, Leonie Jestaedt, Bernd Misselwitz

  • 1Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, D-97080 Würzburg, Germany.

Experimental Neurology
|September 8, 2009
PubMed

Insights

Macrophage infiltration into the central nervous system (CNS) during experimental autoimmune encephalomyelitis (EAE) can occur even with an intact blood-brain barrier (BBB). This finding challenges long-held assumptions about inflammation in CNS disorders like multiple sclerosis (MS).

Area of Science:

  • Neuroimmunology
  • Neuroinflammation
  • Magnetic Resonance Imaging (MRI)

Background:

  • Inflammation is central to central nervous system (CNS) disorders, including multiple sclerosis (MS).
  • Previously, macrophage recruitment into the CNS was thought to be tightly linked to blood-brain barrier (BBB) breakdown.

Purpose of the Study:

  • To investigate the relationship between macrophage infiltration and BBB integrity in experimental autoimmune encephalomyelitis (EAE), an animal model of MS.
  • To challenge the established concept linking macrophage recruitment and BBB disruption in CNS inflammation.

Main Methods:

  • Utilized small superparamagnetic iron oxide particles (SPIO)-enhanced T2-weighted (T2-w) MRI to track macrophage infiltration in EAE.
  • Employed gadofluorine M (Gf), a sensitive contrast agent, to detect BBB leakage in the same animals.
  • Compared SPIO-induced signal loss (macrophage infiltration) with Gf enhancement (BBB disturbance) in EAE lesions.

Main Results:

  • 87 EAE lesions showed SPIO-related signal loss, indicating macrophage infiltration.
  • 57 lesions exhibited Gf enhancement, suggesting BBB disturbance.
  • Concomitant SPIO signal loss and Gf enhancement were observed in only a small minority of lesions.

Conclusions:

  • Macrophage infiltration into the CNS during EAE occurs in areas where the BBB remains functionally closed to humoral factors.
  • This finding persists even when using a highly sensitive contrast agent for BBB disruption detection.
  • The results suggest potential implications for MRI-based disease monitoring and treatment decisions in MS patients.

Related Concept Videos